Cardiologic prophylaxis for Contrast Induced Nephropathy (CarCIN-trial)
- Conditions
- - contrast induced nephropathy- aortic valve stenosis
- Registration Number
- NL-OMON25782
- Lead Sponsor
- Academic Medical Center (AMC) Amsterdam, Department of Cardiology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Other
- Sex
- Not specified
- Target Recruitment
- 80
Inclusion Criteria
Patient is planned for Contrast enhanced CT and/or TAVI-procedure
- eGFR < 60 ml/min/1.73m^2
Exclusion Criteria
- M. Kahler / M. Waldenström
-
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Mean increase in level of serum creatinine 2-5 days after contrast administration
- Secondary Outcome Measures
Name Time Method 1) acute kidney injury defined as an increase in serum creatinine of >25% or 44 umol 2-5 days after contrast administration, <br /> 2) need for renal replacement therapy